Stephen Poor

Stephen Poor

Company: Novartis Institutes for Biomedical Research

Job title: Director


UK trained ophthalmologist working in the Ophthalmology research team at the Novartis Institutes for Biomedical Research since 2006.  Currently Director of the retina research team with an interest developing novel therapies for macular degeneration, diabetic retinopathy and inherited retinal degenerations. 


Panel Discussion: What Does the Future Hold for Complement Therapies? 3:00 pm

This is your opportunity to chat directly with the speakers and voice your own thoughts and research on the future of complement therapiesRead more

day: Day Two

Analysis of Complement in of Donor/Post-Mortem Eyes With & Without Age-Related Macular Degeneration (AMD), Implications for Future Intermediate AMD or Geographic Atrophy (GA) Clinical Trials 12:00 pm

Download the Full Event Guide to find out moreRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.